[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"achievement-rate\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:achievement-rate":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":35,"leadSponsor":37,"locationsCount":4},"100570618","thermal-ablation-versus-parathyroidectomy-for-secondary-hyperparathyroidism-100570618",false,"NCT06709586","Thermal Ablation Versus Parathyroidectomy for Secondary Hyperparathyroidism","Thermal Ablation Versus Parathyroidectomy for Secondary Hyperparathyroidism: a Multicenter Study","Inclusion Criteria:\n\n* persistent serum iPTH (intact parathyroid hormone) levels \\> 800 pg\u002FmL；\n* resistance to calcimimetics, vitamin D, and its analogs, with ineffective conventional internal medicine comprehensive treatment；\n* severe bone pain, osteoporosis, muscle pain, ectopic soft tissue calcification, or other factors affecting quality of life；\n* imaging examinations indicating the presence of at least one enlarged parathyroid gland\n\nExclusion Criteria:\n\n* severe bleeding tendency or coagulation disorders, severe cardiopulmonary abnormalities, and abnormal vital signs such as severe hypertension, arrhythmias, and anemia","ALL","18 Years",{"count":19,"type":20},612,"ESTIMATED","OBSERVATIONAL","Secondary hyperparathyroidism (SHPT), which is frequently associated with chronic kidney disease, leads to problems such as bone pain, fractures, and cardiovascular issues, thereby affecting patients' quality of life. This clinical trial is designed to compare the efficacy of thermal ablation and surgical treatment for SHPT. Parameters including parathyroid hormone levels, serum calcium and phosphorus levels, SHPT-related symptoms (for example, bone pain, muscle weakness), and complication occurrence will be monitored. The advantages involve enabling better treatment decisions for patients, enhancing patients' quality of life, and alleviating the burden on families, in addition to augmenting the clinical knowledge of healthcare providers. However, both treatments carry risks. Thermal ablation may have problems like incomplete ablation, local tissue damage, and blood parameter changes. Surgical risks comprise bleeding, infection, adjacent tissue damage (such as the recurrent laryngeal nerve), and hypoparathyroidism. The investigators will strive to minimize these risks. This trial is of great significance for SHPT treatment, and the investigators welcome participants to contribute to the advancement of medical science in this area.",[24,25,26,27,28],"Achievement Rate","Efficacy and Safety","PTH","Calcium","Clinical Symptoms","NOT_YET_RECRUITING","2024-11-26",{"date":32,"type":33},"2024-11-29","ACTUAL",{"date":30,"type":20},{"date":36,"type":20},"2028-12-30",{"name":38,"class":39},"Chinese PLA General Hospital","OTHER"]